118 related articles for article (PubMed ID: 10958939)
1. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K
Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939
[TBL] [Abstract][Full Text] [Related]
2. [Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH)].
Herrera JC; Isaza LF; Ramírez JL; Vásquez G; Muñetón CM
Biomedica; 2010; 30(3):390-400. PubMed ID: 21713341
[TBL] [Abstract][Full Text] [Related]
3. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
Kobayashi M; Kawashima A; Mai M; Ooi A
Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 17 copy numbers and incidence of p 53 gene deletion in gastric cancer cells. Dual color fluorescence in situ hybridization analysis.
Suzuki S; Tenjin T; Shibuya T; Tanaka S
Nihon Ika Daigaku Zasshi; 1997 Feb; 64(1):22-9. PubMed ID: 9119949
[TBL] [Abstract][Full Text] [Related]
5. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression.
Li X; Tsuji T; Wen S; Mimura Y; Sasaki K; Shinozaki F
Cancer; 1997 Jun; 79(12):2314-9. PubMed ID: 9191518
[TBL] [Abstract][Full Text] [Related]
6. Analysis of MYC and chromosome 8 copy number changes in gastrointestinal cancers by dual-color fluorescence in situ hybridization.
Takahashi Y; Shintaku K; Ishii Y; Asai S; Ishikawa K; Fujii M
Cancer Genet Cytogenet; 1998 Nov; 107(1):61-4. PubMed ID: 9809036
[TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 gene deletions in colorectal cancers using fluorescence in situ hybridization.
Nanashima A; Tagawa Y; Yasutake T; Taniguchi Y; Sawai T; Nakagoe T; Ayabe H
Surg Today; 1997; 27(11):999-1004. PubMed ID: 9413050
[TBL] [Abstract][Full Text] [Related]
8. Detection of structural aberrations of chromosome 17 in malignant gliomas by fluorescence in situ hybridization (FISH).
Kwak T; Nishizaki T; Nakayama H; Kakino S; Ito H; Kimura Y
Acta Oncol; 1995; 34(1):27-30. PubMed ID: 7865231
[TBL] [Abstract][Full Text] [Related]
9. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
12. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.
Sauter G; Deng G; Moch H; Kerschmann R; Matsumura K; De Vries S; George T; Fuentes J; Carroll P; Mihatsch MJ
Am J Pathol; 1994 Apr; 144(4):756-66. PubMed ID: 8160775
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma.
Khayat AS; Guimarães AC; Calcagno DQ; Seabra AD; Lima EM; Leal MF; Faria MH; Rabenhorst SH; Assumpção PP; Demachki S; Smith MA; Burbano RR
BMC Gastroenterol; 2009 Jul; 9():55. PubMed ID: 19619279
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization.
Kawai T; Hiroi S; Nakanishi K; Sakurai Y; Torikata C
Pathol Int; 2004 Jun; 54(6):413-9. PubMed ID: 15144400
[TBL] [Abstract][Full Text] [Related]
15. Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization.
Kondo M; Marusawa H; Ueda Y; Katsurada A; Kawasome C; Takami S; Kinoshita M; Ikai I; Yamaoka Y; Chiba T
J Gastroenterol Hepatol; 2004 Sep; 19(9):1066-73. PubMed ID: 15304126
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
18. [Gene TP53 and digestive cancers].
Tominaga O; Salmon RJ; Laurent-Puig P
Gastroenterol Clin Biol; 1993; 17(3):187-96. PubMed ID: 8392475
[No Abstract] [Full Text] [Related]
19. Importance of cytogenetic markers for multiple primary carcinomas in colorectal cancer: chromosome 17 and p53 locus translocation.
Tagawa Y; Nanashima A; Tsuji T; Sawai T; Yamaguchi H; Yasutake T; Nakagoe T; Ayabe H
J Gastroenterol; 1998 Oct; 33(5):670-7. PubMed ID: 9773931
[TBL] [Abstract][Full Text] [Related]
20. Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH.
Takahashi Y; Ishii Y; Nishida Y; Ikarashi M; Nagata T; Nakamura T; Yamamori S; Asai S
Cancer Genet Cytogenet; 2006 Jul; 168(1):30-5. PubMed ID: 16772118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
